The innovative drug Polyhemostat in the treatment of bleeding

V. Zubritsky; Зубрицкий В.; V. Kukes; Кукес В.; R. Chilova; Чилова Р.; V. Vechorko; Вечорко В.; I. Tarasov; Тарасов И.; G. Proklova; Проклова Г.

doi:10.29296/25877305-2018-07-07

The innovative drug Polyhemostat in the treatment of bleeding

Authors: Zubritsky V.¹, Kukes V.², Chilova R.³, Vechorko V.⁴, Tarasov I.⁵, Proklova G.³
Affiliations:
1. Institute of Sociomedical Technologies, Moscow State University of Food Production
2. Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation
3. I.M. Sechenov First Moscow State Medical University (Sechenov University)
4. O.M. Filatov City Clinical Hospital Fifteen
5. Lyubertsy District Hospital Two
Issue: Vol 29, No 7 (2018)
Pages: 35-39
Section: Articles
URL: https://journals.eco-vector.com/0236-3054/article/view/117177
DOI: https://doi.org/10.29296/25877305-2018-07-07
ID: 117177

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

The innovative drug Polyhemostat has been designed and patented by Russian scientists and registered by the Ministry of Health of the Russian Federation. The drug has been undergone pre- and post-registration clinical studies in a number of leading Russian clinics and military hospitals. The paper considers the experience in topically applying Polyhemostat.